Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V3-Myoma in uterine fibroids
NCT03550703Phase 2Unknown
- Sponsor
- Immunitor Inc.
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Therapeutic Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of V3-Myoma in Uterine Fibroids (UF), sponsored by Immunitor Inc.. Status: unknown.
02
Drugs
V3-Myoma
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT03550703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03550703.